文献速递造血干细胞移植与细胞治疗

肠道菌群动态分析作为造血干细胞移植预后因素的研究

Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.
PubMed 文献 · Br J Haematol · 2019-09-30

该研究利用16S rRNA基因测序和uniFrac距离分析,对异基因和自体造血干细胞移植患者移植前后的粪便样本进行每日纵向监测。结果发现异基因移植患者的肠道菌群与健康对照及自体移植受者显著不同,双歧杆菌和产丁酸菌比例显著降低。菌群组成保持稳定的亚组临床过程良好,而菌群偏倚的患者移植后并发症发生率和死亡率较高,提示肠道菌群稳定性与移植结局密切相关。

要点

  • 异基因造血干细胞移植患者肠道菌群与健康对照及自体移植受者显著不同。
  • 异基因移植患者双歧杆菌和产丁酸菌比例显著低于健康对照。
  • 菌群组成稳定的异基因移植患者临床过程良好,菌群偏倚者并发症和死亡率高。

核心结论

  • 肠道菌群的稳定性与造血干细胞移植的结局密切相关。

研究设计与样本

  • 采用细菌16S核糖体RNA基因新一代测序结合uniFrac距离分析,对造血干细胞移植患者移植前后每日采集的粪便样本进行纵向菌群组成分析。

主要发现

  • 异基因造血干细胞移植患者的肠道菌群与健康对照及自体移植受者存在显著差异。
  • 异基因移植患者中双歧杆菌和归类为产丁酸菌的菌属比例显著低于健康对照。
  • 异基因移植受者中菌群组成保持稳定的亚组临床过程良好。
  • 菌群偏倚的异基因移植患者移植后并发症发生率和死亡率较高。

临床怎么用

  • 监测造血干细胞移植患者肠道菌群组成及其稳定性可能有助于预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The human gut harbours diverse microorganisms, and gut dysbiosis has recently attracted attention because of its possible involvement in various diseases. In particular, the lack of diversity in the gut microbiota has been associated with complications of haematopoietic stem cell transplantation (HSCT), such as infections, acute graft-versus-host disease and relapse of primary disease, which lead to a poor prognosis. However, few studies have serially examined the composition of the intestinal microbiota after HSCT. In this study, we demonstrated, using next-generation sequencing of the bacterial 16S ribosomal RNA gene, combined with uniFrac distance analysis, that the intestinal microbiota of patients undergoing allogeneic HSCT substantially differed from that of healthy controls and recipients of autologous transplants. Faecal samples were obtained daily throughout the clinical course, before and after transplantation. Notably, the proportions of Bifidobacterium and genera categorized as butyrate-producing bacteria were significantly lower in patients with allogeneic HSCT than in healthy controls. Furthermore, among allogeneic transplant recipients, a subgroup with a preserved microbiota composition showed a benign course, whereas patients with a skewed microbiota showed a high frequency of complications and mortality after transplantation. Thus, we conclude that the stability of intestinal microbiota is critically involved in outcomes of HSCT.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kusakabe S, Fukushima K, Maeda T, et al. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol. 2019. PMID: 31566729. doi:10.1111/bjh.16205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。